Patents Represented by Attorney Scully, Scott, Murphy & Pressser
  • Patent number: 6974575
    Abstract: The present invention provides genetically engineered type I/type II hybrid BVDV viruses. The hybrid viruses, as well as the hybrid viral genome, can be used in immunogenic compositions and vaccines for protecting cattle from BVDV infection.
    Type: Grant
    Filed: August 27, 2002
    Date of Patent: December 13, 2005
    Assignees: Pfizer Inc., Pfizer Products Inc.
    Inventors: Xuemei Cao, Gabriele M. Zybarth
  • Patent number: 5795578
    Abstract: The present invention is directed to a gene encoding an envelope glycoprotein of equine herpesvirus type 1 (EHV-1), the glycoprotein D (gD) gene, its gene product and antibodies directed against gD polypeptides. The envelope glycoproteins of herpesvirus are major targets of the inmune response to herpesviral infection. Hence, an important aspect of this invention is directed towards a vaccine against EHV-1 and treatment of EHV-1 infection by anti-EHV-gD antibodies or antisera.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: August 18, 1998
    Assignee: Research Corporation Technologies, Inc.
    Inventor: Dennis J. O'Callaghan